A survey of compliance: Medicaid's mandated blood lead screenings for children age 12-18 months in Nebraska

Marlene Wilken; Sarah Currier; Carla Abel-Zieg; Linda A. Brady

doi:10.1186/1471-2458-4-4

A survey of compliance: Medicaid's mandated blood lead screenings for children age 12-18 months in Nebraska

Marlene Wilken, Sarah Currier, Carla Abel-Zieg, Linda A. Brady

Interdisciplinary Studies

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

Background: To determine the frequency of Medicaid mandated blood lead level (BLL) screening compliance rates by clinical site. Methods: Retrospective chart review for evidence of BLLs. Data analyses were conducted using frequencies, percentages & chi-square. Results: The overall incidence of documented BLLs was 78.9% with one clinic demonstrating 100% BLLs while the others had 72%. Screening rates differed significantly by clinical site (X ² = 18.460, df = 3, p <0.001). Conclusion: Although universal blood lead screening is mandated, there were missed opportunities to obtain BLLs in 21.1% of the records reviewed. Only one clinic had 100% documentation of BLLs when children on Medicaid were seen between the ages of 12-18 months.

Original language	English (US)
Article number	4
Pages (from-to)	1-3
Number of pages	3
Journal	BMC Public Health
Volume	4
DOIs	https://doi.org/10.1186/1471-2458-4-4
State	Published - Feb 23 2004

All Science Journal Classification (ASJC) codes

Public Health, Environmental and Occupational Health

Access to Document

10.1186/1471-2458-4-4

Fingerprint Dive into the research topics of 'A survey of compliance: Medicaid's mandated blood lead screenings for children age 12-18 months in Nebraska'. Together they form a unique fingerprint.

Cite this

@article{cebb1374468449c28ebfeb13eb07e189,

title = "A survey of compliance: Medicaid's mandated blood lead screenings for children age 12-18 months in Nebraska",

abstract = "Background: To determine the frequency of Medicaid mandated blood lead level (BLL) screening compliance rates by clinical site. Methods: Retrospective chart review for evidence of BLLs. Data analyses were conducted using frequencies, percentages & chi-square. Results: The overall incidence of documented BLLs was 78.9% with one clinic demonstrating 100% BLLs while the others had 72%. Screening rates differed significantly by clinical site (X 2 = 18.460, df = 3, p <0.001). Conclusion: Although universal blood lead screening is mandated, there were missed opportunities to obtain BLLs in 21.1% of the records reviewed. Only one clinic had 100% documentation of BLLs when children on Medicaid were seen between the ages of 12-18 months.",

author = "Marlene Wilken and Sarah Currier and Carla Abel-Zieg and Brady, {Linda A.}",

year = "2004",

month = feb,

day = "23",

doi = "10.1186/1471-2458-4-4",

language = "English (US)",

volume = "4",

pages = "1--3",

journal = "BMC Public Health",

issn = "1471-2458",

publisher = "BioMed Central",

}

TY - JOUR

T1 - A survey of compliance

T2 - Medicaid's mandated blood lead screenings for children age 12-18 months in Nebraska

AU - Wilken, Marlene

AU - Currier, Sarah

AU - Abel-Zieg, Carla

AU - Brady, Linda A.

PY - 2004/2/23

Y1 - 2004/2/23

N2 - Background: To determine the frequency of Medicaid mandated blood lead level (BLL) screening compliance rates by clinical site. Methods: Retrospective chart review for evidence of BLLs. Data analyses were conducted using frequencies, percentages & chi-square. Results: The overall incidence of documented BLLs was 78.9% with one clinic demonstrating 100% BLLs while the others had 72%. Screening rates differed significantly by clinical site (X 2 = 18.460, df = 3, p <0.001). Conclusion: Although universal blood lead screening is mandated, there were missed opportunities to obtain BLLs in 21.1% of the records reviewed. Only one clinic had 100% documentation of BLLs when children on Medicaid were seen between the ages of 12-18 months.

AB - Background: To determine the frequency of Medicaid mandated blood lead level (BLL) screening compliance rates by clinical site. Methods: Retrospective chart review for evidence of BLLs. Data analyses were conducted using frequencies, percentages & chi-square. Results: The overall incidence of documented BLLs was 78.9% with one clinic demonstrating 100% BLLs while the others had 72%. Screening rates differed significantly by clinical site (X 2 = 18.460, df = 3, p <0.001). Conclusion: Although universal blood lead screening is mandated, there were missed opportunities to obtain BLLs in 21.1% of the records reviewed. Only one clinic had 100% documentation of BLLs when children on Medicaid were seen between the ages of 12-18 months.

UR - http://www.scopus.com/inward/record.url?scp=2642514924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2642514924&partnerID=8YFLogxK

U2 - 10.1186/1471-2458-4-4

DO - 10.1186/1471-2458-4-4

M3 - Review article

C2 - 15053833

AN - SCOPUS:2642514924

VL - 4

SP - 1

EP - 3

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

M1 - 4

ER -